CYTO365 is proud to yet again be a sponsor of this event.
This conference is open to clinical governance, healthcare managers, nurses, pharmacists, workers’ rights entities and healthcare establishments from across Europe, the UK, and focusses on current scientific evidence, the risks to health, and best practice, and the future responsibilities of employers regards hazardous drug exposure management and in line with the recently published ISOPP Standards for the Safe Handling of Cytotoxics 2022, the EU Guidance for the Safe Management of Hazardous Medicinal Products at work 2023, and the ETUI (European Trade Union Institute) List of Hazardous Medicinal Products 2022.
https://www.safercancercare.com/about-the